GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
GTHX
Delisted
GTHX was delisted on the 17th of September, 2024.
115 hedge funds and large institutions have $123M invested in G1 Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 32 increasing their positions, 30 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
57% less capital invested
Capital invested by funds: $287M → $123M (-$164M)
Holders
115
Holding in Top 10
–
Calls
$550K
Puts
$341K
Top Buyers
| 1 | +$4.08M | |
| 2 | +$2.96M | |
| 3 | +$2.71M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$1.97M |
| 5 |
D.E. Shaw & Co
New York
|
+$1.9M |
Top Sellers
| 1 | -$11M | |
| 2 | -$7.81M | |
| 3 | -$4.32M | |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$2.79M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$2.02M |